This suggests that beyond anti-angiogenesis, the inhibition of VEGF-VEGFR signaling pathway would likely work in MPM by inhibiting the autocrine cell growth loop, lacking in other cancer cells such as lung or pancreatic cancer, in which inhibition of VEGFR mainly functions via anti-angiogenesis. This evidence concerns the gene KDR and cancer.